Where is QuellTX headquartered?

QuellTX is located in London, england.

Who invested in QuellTX ?

QuellTX has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for QuellTX ?

QuellTX closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

quell-tx.com

QuellTX

QuellTX is an England-based biopharmaceutical company that develops and commercializes T cell therapies for the treatment of autoimmune and inflammatory diseases.

Business Model:

Revenue: $2M

Employees: 11-50

Geographic Data

Address: 84 Wood Lane

City: London

State: england

Zip: W12 OBZ

Country: GB

Financial Info

Stage:

series b

Raised Last:

$156M

Raised Total:

$240M

Social

Crunchbase

Metrics

6,684,319Website Global Rank

768Website Monthly Traffic

Twitter Followers

Description

QuellTX is an England-based biopharmaceutical company that develops and commercializes T cell therapies for the treatment of autoimmune and inflammatory diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
11/2021	Series B		$0	Point72 British Patient Capital Fidelity Management and Research Company Janus Henderson Investors Jeito Capital Monashee Investment Management Ridgeback Capital SV Health Investors Syncona Partners LLP Tekla Capital Management Point72 British Patient Capital Fidelity Management and Research Company Janus Henderson Investors Jeito Capital Monashee Investment Management Ridgeback Capital SV Health Investors Syncona Partners LLP Tekla Capital Management
2/2021	Series A		$0	Syncona Partners LLP UCL Technology Fund Syncona Partners LLP UCL Technology Fund
2/2021	Series A		$35.7M	Syncona Ltd UCL Technology Fund
5/2019	Series A		$48.3M	Syncona Ltd
5/2019	Series A	2	$44.5M	Syncona Partners LLP UCL Technology Fund Syncona Partners LLP UCL Technology Fund
11/2021	Series B	10	$156M	Jeito Capital Ridgeback Capital SV Health Investors Fidelity Management & Research Company Syncona Future Fund: Breakthrough program Janus Henderson Investors Monashee Investment Management Point72 Tekla Capital Management LLC British Patient Capital Fidelity Management and Research Company Janus Henderson Investors Jeito Capital Monashee Investment Management Point72 Ridgeback Capital SV Health Investors Syncona Partners LLP Tekla Capital Management
2/2021	Series A	2	$40M	Syncona Partners LLP UCL Technology Fund Syncona Partners LLP UCL Technology Fund

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details